Finnish decree outlines fee payment schedule of new medicines agency
This article was originally published in SRA
Executive Summary
The Finnish government has approved a new decree specifying the fees payable by the pharmaceutical industry to the country’s new medicines agency, Fimea, which started operations in November last year1,2.